Studies of the increased susceptibility of African Americans to FSGS have implicated variants of apolipoprotein L1 (APOL1) (Genovese et al. 2013) to lysosomal dysfunction in podocytes. This evidence concerns the gene APOL1 and focal segmental glomerulosclerosis.